Safety and biologic activity of intravenous BCL-2 antisense oligonucleotide (G3139) and taxane chemotherapy in patients with advanced cancer

Michael J. Morris, Carlos Cordon-Cardo, William K. Kelly, Susan F. Slovin, Karen Siedlecki, Kevin P. Regan, Robert S. DiPaola, Mohamed Rafi, Neal Rosen, Howard I. Scher

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and biologic activity of intravenous BCL-2 antisense oligonucleotide (G3139) and taxane chemotherapy in patients with advanced cancer'. Together they form a unique fingerprint.

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science